These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25237241)

  • 1. Essence of the revised guideline for the management of hyperuricemia and gout.
    Yamanaka H; Metabolism TG
    Japan Med Assoc J; 2012 Jul; 55(4):324-9. PubMed ID: 25237241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese guideline for the management of hyperuricemia and gout: second edition.
    Yamanaka H;
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1018-29. PubMed ID: 22132951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of hyperuricemia in occupational health: with reference to "guidelines for the management of hyperuricemia and gout"].
    Nakajima H
    Sangyo Eiseigaku Zasshi; 2003 Jan; 45(1):12-9. PubMed ID: 12624869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Revised version of Guideline for the Management of Hyperuricemia and Gout].
    Yamanaka H
    Nihon Rinsho; 2008 Apr; 66(4):643-6. PubMed ID: 18409508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S
    Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of hyperuricemia with urate deposition.
    Desideri G; Puig JG; Richette P
    Curr Med Res Opin; 2015; 31 Suppl 2():27-32. PubMed ID: 26414734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Practice guideline for patients with hyperuricemia/gout].
    Huang YF; Yang KH; Chen SH; Xie Y; Huang CB; Qing YF; He DY; Wu LJ; Zhan F; Wang XQ; Zhou YQ; Kong QC; Wang K; Schlesinger N; Xu DT; Ma XJ; Gu JR
    Zhonghua Nei Ke Za Zhi; 2020 Jul; 59(7):519-527. PubMed ID: 32594685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gout and cardiovascular risk].
    Němec P
    Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperuricemia and gout: diagnosis and therapy].
    Tausche AK; Unger S; Richter K; Wunderlich C; Grässler J; Roch B; Schröder HE
    Internist (Berl); 2006 May; 47(5):509-20; quiz 521. PubMed ID: 16586130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review.
    Jalal DI
    Curr Med Res Opin; 2016 Nov; 32(11):1863-1869. PubMed ID: 27470664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2011 recommendations for the diagnosis and management of gout and hyperuricemia.
    Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL
    Phys Sportsmed; 2011 Nov; 39(4):98-123. PubMed ID: 22293773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout).
    Becker MA
    Rheum Dis Clin North Am; 1988 Aug; 14(2):377-94. PubMed ID: 3051156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy].
    Eliseev MS; Novikova AM
    Ter Arkh; 2019 May; 91(5):120-128. PubMed ID: 32598686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperuricemia and Gout].
    Delbarba E; Terlizzi V; Dallera N; Izzi C; Scolari F
    G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Daniel K. Inouye College of Pharmacy Scripts: Perspectives on the Epidemiology of Gout and Hyperuricemia.
    Roman YM
    Hawaii J Med Public Health; 2019 Feb; 78(2):71-76. PubMed ID: 30766768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia.
    Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL;
    Postgrad Med; 2011 Nov; 123(6 Suppl 1):3-36. PubMed ID: 22156509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout.
    Katayama A; Yokokawa H; Fukuda H; Ono Y; Isonuma H; Hisaoka T; Naito T
    Intern Med; 2019 May; 58(9):1225-1231. PubMed ID: 30626825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperuricemia. When and how to treat?].
    Reuss-Borst MA
    Internist (Berl); 2016 Feb; 57(2):194-201. PubMed ID: 26791735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uptake of 2-C14 urate by erythrocytes in hyperuricemia and in gout (author's transl)].
    Lang F; Greger R; Silbernagel H; Günther R; Deetjen P
    Klin Wochenschr; 1978 Mar; 53(16):261-4. PubMed ID: 682521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.